Sihuan Pharmaceut. Hldgs Ltd. Registered Shares HD-,01
- BID
0.0925
- ASK
0.108
- 47,310 Units40,349 Units
- 07/21, 18:02:52 PM
Sector and Industry
Healthcare, Biopharmaceuticals
Performance (1Y)
35.11%
Market Cap
-
P/E Ratio
57.48
Dividend Yield
1.77 %
Earnings per Share
0.00 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Eli Lilly and Company | 864.54 Bil. | 57.78 Bil. | 46.82 | +86.88 % | 0.00 | - |
| Johnson & Johnson | 425.70 Bil. | 83.48 Bil. | 18.82 | +82.71 % | 0.00 | - |
| AbbVie Inc. | 343.94 Bil. | 54.21 Bil. | 96.78 | -5.29 % | 0.00 | - |
| Roche Holding AG | 286.62 Bil. | 65.80 Bil. | 20.72 | +58.45 % | 0.00 | - |
| AstraZeneca PLC | 244.91 Bil. | 52.09 Bil. | 27.55 | +39.41 % | 0.00 | - |
| NOVARTIS AG | 224.76 Bil. | 48.44 Bil. | 18.30 | +12.45 % | 0.00 | - |
| Merck & Co. Inc. | 221.79 Bil. | 57.55 Bil. | 14.46 | +2.25 % | 0.00 | - |
| Novo-Nordisk AS B | 193.52 Bil. | 41.49 Bil. | 14.11 | +1.54 % | 0.00 | - |
| Amgen Inc. | 150.16 Bil. | 32.57 Bil. | 23.01 | +80.77 % | 0.00 | - |
| Gilead Sciences Inc. | 129.70 Bil. | 26.10 Bil. | 18.10 | +1,599.93 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 0.0925 G | 0 Units |
| PRICE DETERMINATION TIME | 07/21/2026 / 05:47:50 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 0.0945 | 0.088 |
| PREV. DAY'S PRICE | 0.0915 | (07/20) |
| CHANGE DAY BEFORE | +0.00 | 1.09 % |
| 52 WEEK HIGH / LOW | 0.202 (10/07) | 0.081 (06/26) |
Key Figures (in EUR)
| 2023 | 2024 | 2025 | 2026e | 2027e | |
|---|---|---|---|---|---|
EARNINGS PER SHARE | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | - | - |
DIVIDEND YIELD IN % | 0.00 % | 3.18 % | 1.77 % | - | - |
DIVIDEND GROWTH IN % | -100.00 % | - | -0.37 % | - | - |
PRICE - EARNINGS RATIO | - | - | 57.48 | 9.29 | 6.76 |
PRICE - BOOK RATIO | 1.24 | 1.31 | 1.71 | - | - |
PRICE - SALES RATIO | 2.94 | 2.97 | 3.95 | - | - |
PRICE - CASH FLOW RATIO | 17.89 | 16.21 | 703.39 | - | - |
Master Data
| WKN | A1C72G |
| ISIN | BMG8162K1137 |
| SYMBOL | TEL1 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | Sihuan Pharmaceutical |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | - |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Biopharmaceuticals |
| NUMBER OF SHARES | - |
| MARKET CAPITALISATION | - |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 7.02 % | 2.81 % | -32.22 % | -30.15 % | -35.11 % | 25.34 % | -69.70 % | -25.61 % |
| HIGH | 0.10 | 0.10 | 0.14 | 0.18 | 0.20 | 0.20 | 0.31 | 0.18 |
| LOW | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.05 | 0.05 | 0.08 |
Dividende
pro Aktie
Company profile
Sihuan Pharmaceutical Holdings Group Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Medical Aesthetic Products, Innovative Medicine and Other Medicine, and Generic Medicine. The Medical Aesthetic Products refers to the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skin care and others to provide non- or minimally invasive medical aesthetics comprehensive solutions. The company was founded by Feng Sheng Che and Wei Cheng Guo in 2001 and is headquartered in Beijing, China.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.